Capitation payment for pharmacy services. I. Impact on drug use and pharmacist dispensing behavior.
Results of a two-county pilot study in Iowa revealed that capitation may have significant advantages over fee-for-service (FFS) reimbursement in the Medicaid drug program. Consequently, the capitation program was expanded to 32 counties on April 1, 1981 and continued through December 31, 1981. Another 32 counties were used as part of a before:after/experimental:control design. Pharmacists were paid 80% of projected drug expenditures in advance based on the types of Medicaid eligibles who chose them as their providers. The remaining 20% was withheld in an escrow account to be used for supplemental, emergency, and bonus payments. Pharmacists who participated in this experiment were guaranteed that their gross profits on Medicaid prescriptions would remain at least equal to what they would have been if they had remained under the current FFS payment system. Major differences in drug use levels and pharmacist dispensing behavior under capitation financing were observed in the pilot study. However, no such changes associated with payment type were noted in the expanded program. Relative to these findings, a discussion of pharmacist attitudes is presented.
D001291:Attitude of Health Personnel; D002204:Capitation Fee; D004347:Drug Interactions; D011307:Drug Prescriptions / Q000191:economics*; D004363:Drug Utilization / Q000191:economics*; D005249:Fees and Charges; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D007484:Iowa; D008484:Medicaid / Q000191:economics; D010595:Pharmacists; D010865:Pilot Projects; D011364:Professional Practice; D011445:Prospective Payment System; D014505:Urban Population